In addition, high levels of resting memory CD4+ T cells in ccRCC have been associated with improved outcomes because these cells can further differentiate into CD8+ T cells to suppress tumor growth [42]. This evidence concerns the gene CD4 and nonpapillary renal cell carcinoma.